circRNA basic information
circBase ID: -
Name: hsa_circ_Mras
Synonym: -
Host Gene: Mras
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005061
MONDO name: lung adenocarcinoma
Disease details: Lung adenocarcinoma
Disease DO ID:
3910
Disease MeSH ID:
C538231
Disease NCIt ID:
C3512
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

LAC tissues; para-noncancerous; xenograft tumor

Cell lines:

A549; HCC827; H460; Calu-3; HBE

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
DN
Associated gene: ABHD5, ATGL, p53, p65, p-p65
Associated microRNA: -
Biological function: Circ_cMras acts as a tumor suppressor in LAC, inhibiting cell proliferation, migration, invasion and tumor growth, while promoting apoptosis.
Molecular mechanism: Circ_cMras positively regulates ABHD5 and ATGL, increases p53, inhibits NF-kappaB pathway activation, and suppresses LAC progression through the circ_cMras/ABHD5/ATGL/NF-kappaB axis.
Biological pathway or process:

NF-kappaB (inhibits); p53 signaling (promotes); proliferation (inhibits); apoptosis (promotes); migration (inhibits); invasion (inhibits); metastasis (inhibits)

Detected method:
Q
Validation methods:

RNase R Treatment; RT-qPCR; Clinical Sample Validation; Transfection; MTT; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; In Vivo Animal Model

Clinical significance:

Circ_cMras might provide a novel insight for the diagnosis and prognosis of LAC.

Description:

Circ_cMras is down-regulated in lung adenocarcinoma tissues and cells. Its overexpression suppresses proliferation, migration, invasion and xenograft tumor growth, promotes apoptosis, and acts through positive regulation of the ABHD5/ATGL axis with inhibition of NF-kappaB signaling and increased p53.

Confidence score:

0.6278

Other information
Title:

Circular RNA cMras Suppresses the Progression of Lung Adenocarcinoma Through ABHD5/ATGL Axis Using NF-kappaB Signaling Pathway.

Journal: Cancer biotherapy & radiopharmaceuticals
Published: 2023
PubMed ID: 32822232
Study type:

combined biological and clinical study

Data availability: -
Code availability: -